Arbutus Biopharma (ABUS) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ABUS Annual Balance Sheets →
Reviewing balance sheet data across recent quarters allows users to assess how Arbutus Biopharma manages assets, liabilities, and equity through different cycles.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent19.17
Short-term Investments, Total73.45
Cash & Short-term Investments92.00
Accounts receivable179.37
Unbilled Receivables, Current RE0.40
Other Current Assets0.00
Prepaid Expense And Other Assets Current1.52
Total Current Assets273.88
Equipment/Property/Plant Net0.01
Tax Assets, Noncurrent0.00
Other Assets, Noncurrent0.10
Operating Lease Right Of Use Asset-
Total Assets274.03
Liabilities
Accounts Payable and Accrued Liabilities, Current LI2.85
Accrued Liabilities, Current0.74
Other Liabilities, Current0.00
Total Current Liabilities3.36
Total Long-term Debt0.00
Restructuring Reserve, Current RE0.16
Other liabilities, Noncurrent11.77
Operating Lease Liability Current0.63
Liability Related To Sale Of Future Royalties Noncurrent3.28
Total Liabilities15.29
Stockholders' Equity
Common Stock Value1,448.18
Additional Paid In Capital Common Stock74.32
Retained Earnings / Accumulated Deficit-1,215.52
Accumulated Other Comprehensive Income-48.24
Other Equity-48.24
Common Stockholder's Equity258.73
Total Stockholder's Equity258.73
Liabilities & Stockholder's Equity274.03
4 historic quarters locked

Sign in to unlock the full Arbutus Biopharma balance sheet history.

About Arbutus Biopharma Corp Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001447028-26-000045

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.